What You Should Know:
- LexaGene's closes CAD$13 million funding round as it
prepares to launch its gold standard diagnostic device called MiQLab that
applies a proprietary RT-qPCR-based method to analyze each sample's contents
for up to 27 different pathogens in approximately one hour.
- MiQLab is uniquely open-access, which allows users to
customize their tests and create new tests easily. In the case where a new test
was needed because of a mutation, the open-access feature allows new
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
FUJIFILM Sonosite & the CHEST Foundation Partner for COVID-19 Research
What You Should Know:
- FUJIFILM Sonosite, Inc. today announced their
partnership with the CHEST Foundation, the charitable foundation of the
American College of Chest Physicians, on the CHEST Foundation COVID-19 Research
Grant program.
- To support this program, FUJIFILM Sonosite is contributing $70,000 to the foundation and will donate newly launched Sonosite PX ultrasound systems to the selected research award sites.
FUJIFILM Sonosite, Inc.,
the world leader in
Read More
UCSD Partners with Cofactor Genomics to Improve Head and Neck Cancer Outcomes
What You Should Know:
- Physicians at the University of California, San Diego
(UCSD) School of Medicine and Cofactor Genomics ink a partnership to improve a
physician’s ability to predict tumor response to immunotherapy, specifically in
recurrent and metastatic squamous cell carcinoma of the head and neck.
- The data generated in this collaboration will further
expand clinical evidence presented by Washington University physicians, where
Cofactor’s technology showed superiority over the
Read More
Uniphore CEO Talks Call Centers & Why Contact Tracing is Failing
Amid the COVID-19 pandemic, all call centers have now been asked to play a vital role, acting as the hubs for contact tracing to help track and contain the spread of the virus. It’s estimated that the U.S. needs to employ 100,000 to 300,000 contact tracers for this to be an effective program. However, call center representatives that have a healthcare background and are trained to handle these sensitive calls are in short supply, so states have had to get “creative about finding the workforce.”
Read More
KPMG Launches COVID-19 Convalescent Plasma Donor Matching Solution
What You Should Know:
- KPMG offers its data & analytics capabilities to
address emerging challenges tied to matching recovered patients with those in
clinical trials to receive convalescent plasma.
- KPMG’s capabilities can make the plasma donation process easier
and more efficient by automating the complex tasks and logistics associated
with the data collection, qualification and matching process by performing
statistical analytics, and using artificial intelligence (AI),
Read More
UK Cancer Diagnostics Startup Biofidelity Raises $12M
What You Should Know:
- UK-based Biofidelity raises $12 million in Series A funding to accelerate the launch of disruptive cancer diagnostic technology.
- The funding will be used to bring technology to market,
enabling a dramatic simplification of precision genetic testing to ensure many
more cancer patients receive optimal diagnosis and therapy.
Biofidelity Ltd, a Cambridge,
UK-based cancer diagnostics company, today announced it has raised $12 million
in Series A funding led by
Read More
Castor Raises $12M to Advance COVID-19 Research Through Clinical Trial and Data Automation
What You Should Know:
- Castor raises $12M in Series A funding to further their
support for COVID-19 research through clinical trial and data automation.
- With 4,000 live studies and 2,000,000 enrolled patients
across 90 countries, Castor will use the funding to further invest in enabling
patient-centric, data-powered clinical trials.
Castor, a Hoboken,
New Jersey startup using automation and data reuse to simplify the entire
clinical trial process, announced $12M in Series A
Read More
THREAD Lands $50M for Decentralized Clinical Trial Research Platform
What You Should Know:
- THREAD receives an additional $50 million capital commitment from Water Street and JLL Partners to expand its decentralized clinical trial research platform
- THREAD is an innovative technology and service
provider that increases participant engagement by enabling pharmaceutical
companies and contract research organizations to remotely capture data from
participants and sites during, in between and in lieu of in-clinic
visits.
- This major investment
Read More
Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform
What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Bayer, Verizon Partner to Build Next-Gen Global Network Infrastructure
What You Should Know:
- Bayer announced that it has chosen Verizon
Business to build a next-gen global network infrastructure to support the
pharmaceutical giant’s global business operations.
- Verizon will enhance Bayer’s existing network
capabilities to enable easier and more cost-effective network management and
will deploy next-generation network technologies, such as software-defined
networking (SDN), to further improve resilience, flexibility,
Read More
